Estrogen therapy isn't dangerous it's evidence-based medicine for menopause

For decades, women have been told hormone therapy was too risky, leaving them to suffer through debilitating menopause symptoms. This fear-based approach was never sound medical practice: it was abandonment dressed up as caution.

New analysis of decades of research reveals that for healthy women in their 50s or within 10 years of menopause, estrogen therapy is both safe and effective. Leading medical organizations now support its use as a first-line treatment for menopause symptoms.

For healthy women navigating perimenopause and early menopause, estrogen therapy is being reframed as what it should have been all along: a safe, effective, and often necessary tool

Timing Changes Everything

Starting estrogen therapy during perimenopause or early menopause carries different risks than starting it years later. For women in their 50s, the feared risks simply weren't present.

Fear Based on Flawed Data

The original studies that created hormone therapy fear used women averaging age 63, many in their 70s. This doesn't apply to women experiencing active menopause symptoms.

Updated Medical Guidelines

Leading medical organizations now recommend estrogen therapy as first-line treatment for menopause symptoms in appropriate candidates. The evidence base has fundamentally shifted.

Get Expert Evaluation

Work with a menopause-trained physician who understands current evidence and can assess whether estrogen therapy is right for your individual situation and health profile.

Ready to go deeper?

Three Ways to Connect With Dr. Moyers

  Apply for Membership (Fort Worth, TX patients) — Concierge-level women's health care tailored to your body, your symptoms, and your life.

  Weekly Newsletter — Evidence-based insights on hormones, vitality, and midlife health. Free, wherever you are.

  Sky Women's Health Podcast — Real conversations about the health topics mainstream medicine skips.

Apply for Membership Join the Newsletter Listen to Podcast

You don't have to suffer through menopause symptoms because of outdated fears. Evidence-based menopause care means having access to treatments that actually work. If you're ready for comprehensive, individualized menopause care that puts your quality of life first, consider applying for membership at Sky Women's Health.

Frequently Asked Questions

Is it safe to take estrogen during menopause now?

For most healthy women who are under the age of 60 or within 10 years of their last menstrual period, systemic estrogen therapy is considered safe. Decades of follow-up research from the Women's Health Initiative and other studies have clarified that the initial fears were based on data from an older population. When started earlier, the benefits of hormone therapy, such as relief from symptoms and protection of bone health, generally outweigh the risks. A conversation with a doctor is essential to evaluate your personal health history and determine if it is a safe option for you.

What are the new guidelines for hormone replacement therapy?

The new guidelines, supported by major medical bodies like The Menopause Society, state that hormone therapy is the most effective treatment for vasomotor symptoms (hot flashes) and genitourinary syndrome of menopause (GSM). They confirm that for most healthy, symptomatic women under 60, the benefits are greater than the potential risks. The guidelines also emphasize the importance of personalization, considering a woman's age, health history, and preferences when choosing the type, dose, and route of administration for her hormone therapy.

What were the risks found in the original Women's Health Initiative (WHI) study?

In 2002, the Women's Health Initiative study made international headlines when it was stopped early, with reports claiming that hormone therapy caused breast cancer, heart disease, stroke, and blood clots. Hormone prescriptions plummeted by as much as 80%. A generation of women abandoned treatment — and a generation of physicians stopped offering it. What was not clearly communicated at the time: the breast cancer finding was based on a nominal, unadjusted hazard ratio that "almost reached nominal statistical significance" — and when properly adjusted for multiple outcomes, the confidence intervals crossed 1.0, meaning the result was not statistically significant. In plain terms, the WHI did not actually prove that hormone therapy caused breast cancer. The reported 26% relative risk increase translated to fewer than 8 additional cases of invasive breast cancer per 10,000 women per year — an absolute risk so small it is classified as rare, and comparable to the risk of drinking one glass of wine daily. Furthermore, the study results were not adjusted for participants' pre-existing conditions, and may have been skewed by an unusually low rate of breast cancer in the placebo group. Perhaps most importantly, the WHI studied one specific regimen — oral conjugated equine estrogen combined with medroxyprogesterone acetate — in women with an average age of 63, most of whom were more than a decade past menopause. The original WHI publication itself stated that results "do not necessarily apply to lower dosages, to other formulations of oral estrogens and progestins, or to estrogens and progestins administered through the transdermal route." That disclaimer was largely ignored and caused profound harm to women who were denied effective treatment based on a misread study. The picture has continued to clarify. More recent WHI publications acknowledge that estrogen alone actually reduces the risk of breast cancer by 23% while reducing breast cancer death by 40%. And contemporary evidence shows that natural progesterone does not carry a significant increase in relative breast cancer risk — because not all progestogens are the same.

Who is a good candidate for estrogen therapy in menopause?

The short answer: more women than you might think. Current guidelines support hormone therapy for healthy women under 60, or within 10 years of their final menstrual period, who are experiencing bothersome symptoms — hot flashes, night sweats, sleep disruption, mood changes, brain fog, or vaginal dryness. Women at risk for osteoporosis are also strong candidates, as hormone therapy remains one of the most effective tools we have for bone protection. But candidacy is not a simple checklist. It is a conversation. Factors like your age, how long you have been in menopause, your symptom burden, your cardiovascular history, your bone density, your quality of life, and yes — your cancer history — all matter and all deserve individualized consideration.

Making an Informed Choice for Your Menopause Journey

The conversation around estrogen has fundamentally changed. The narrative has moved from one of universal risk to one of personalized, informed choice. For too long, women were told to simply endure menopause, but a deeper understanding of the science has reopened the door to effective relief.

For many women, hormone therapy is not just about managing hot flashes. It is a powerful menopause treatment that can protect long-term bone and cardiovascular health while restoring sleep, mood, and overall vitality. The goal is no longer to use the lowest dose for the shortest time, but the right dose for the right person for as long as it is beneficial.

If you are struggling with the symptoms of perimenopause or menopause, you have options. The most important step you can take is to find a healthcare provider who is up-to-date on the current guidelines. Arm yourself with good information, ask questions, and work with your doctor to create a plan that addresses your unique symptoms, health history, and goals for a vibrant life.

Dr. Carolyn Moyers, DO

FACOG · Menopause Society Certified · Sexual Health Fellowship

Dr. Moyers is a board-certified OB/GYN with specialized fellowship training in menopause medicine and sexual health. She is the founder of Sky Women's Health, a membership practice dedicated to providing evidence-based, comprehensive care for women navigating hormonal changes.

Your next step

You Deserve Care That Actually Listens

Whether you're in Fort Worth and ready for personalized care, or anywhere in the world and looking to stay informed — there's a place for you here.

Membership — Concierge women's health care for Fort Worth, TX patients
Newsletter — Free weekly insights on hormones and vitality, available everywhere
Podcast — Real conversations mainstream medicine skips

Apply for Membership Join the Newsletter Listen to Podcast